02196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 17.32
+0.99%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenHKD 17.17
From 52W high−39.86%
Volume5.56M
Market capHKD 45.71B
P/E (TTM)7.8x
P/S (TTM)0.6x
Div yield2.60%
Key dataSep 18, 2026
Open
HKD 17.17
From 52W high
−39.86%
Volume
5.56M
Market cap
HKD 45.71B
ValuationView details →
P/E (Fwd)
22.0x
EV/EBITDA
10.4x
P/E (TTM)
7.8x
RSI (14)
56.3
MomentumView details →
1D Return
+0.99%
YTD Return
−11.41%
Similar companies
Latest newsMore news →
Shanghai Fosun Pharmaceutical (Group) repurchased 1.3 million of its own shares on September 18 at HK$17.35–17.58 per share for about HK$22.77 million, bringing cumulative buybacks to 9.759 million shares, or 1.8% of issued shares.2d agoShanghai Fuzhenkang Biotechnology Co., Ltd. was established, jointly held by Fosun Pharma's wholly owned subsidiary Fosun Diagnostics Technology (Shanghai) Co., Ltd. and other shareholders.4d agoFosun Pharma repurchased 1.3 million of its own shares on the Hong Kong Stock Exchange on September 16, 2026 at HK$16.91–17.26 per share for a total of HK$22.2439 million, to be held as treasury shares.4d ago